Dr. Walsh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Avenue
New York, NY 10065
Summary
- Dr. Michael Walsh is a pediatric hematologist/oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center.
Education & Training
- University of TennesseeFellowship, Pediatric Hematology/Oncology, 2011 - 2014
- John Hopkins UniversityResidency, Pediatrics/Medical Genetics and Genomics, 2007 - 2011
- Johns Hopkins UniversityInternship, Pediatrics, 2006 - 2007
- University College of Dublin National Univ SOMClass of 2005
- Boston CollegeBA, Economics, 1995 - 1999
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2014 - 2026
- NJ State Medical License 2023 - 2025
- CT State Medical License 2023 - 2024
- TN State Medical License 2012 - 2016
- MD State Medical License 2010 - 2011
- American Board of Pediatrics Pediatrics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- Rising Stars, Super Doctors Superdoctors.com, 2021
- Young Investigator Award American Society of Pediatric Hematology Oncology (ASPHO), 2016
- Margaret Ellen Nielsen Fellowship Award McKusick Nathan Institute of Genetic Medicine, Johns Hopkins, 2009
Clinical Trials
- Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer Start of enrollment: 2019 Apr 17
Publications & Presentations
PubMed
- Radiation-Associated Secondary Cancer in Patients With Breast Cancer Harboring TP53 Germline Variants.Gustav Y Cederquist, Lillian A Boe, Michael Walsh, Gary M Freedman, Kara N Maxwell
JAMA Oncology. 2024-11-01 - Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy.Luke D Maese, Marcin W Wlodarski, Sun Young Kim, Alison A Bertuch, Gaelle Bougeard
Clinical Cancer Research. 2024-10-01 - 1 citationsUniversal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings.Ozge Ceyhan-Birsoy, Elise Fiala, Satshil Rana, Margaret Sheehan, Jennifer Kennedy
Haematologica. 2024-10-01
Journal Articles
- Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumorsElise M. Fiala, Gowtham Jayakumaran, Audrey Mauguen, Jennifer A. Kennedy, Nancy Bouvier, Yelena Kemel, Megan Harlan Fleischut, Anna Maio, Erin E. Salo-Mullen, Margaret..., Nature Cancer, 2/15/2021
- Pathogenic Loss-of-Function Germline TERT Mutations in Patients With Solid TumorsMichael F. Walsh, MD; Rosalba Sacca, PhD; Temima Wildman, MS; Kimberly Amoroso, MS; Jennifer Kennedy, MS; Liying Zhang, MD, PhD; Ozge Birsoy, PhD; Diana Mandelker, MD,..., JCO PO, 10/23/2019
Books/Book Chapters
Press Mentions
- JHAH and TruDoc Healthcare Partner to Offer Hospital at Home Services in Saudi ArabiaSeptember 26th, 2024
Grant Support
- Determining the Heritable Basis for Acute Lymphoblastic LeukemiaV Foundation for Cancer Research2015–Present
Committees
- Representative/Liason to Commision on Cancer, American Collge of Medical Genetics 2020 - Present
- Chair, ClinGen Somatic/Germline Variant Curation 2016 - Present
Research History
- Post Doc Fellow, Downing LabPediatric Cancer Genome Project, St. Jude Children's Research Hospital2011 - 2014
- Genetic Fellow, Armanios LabMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins2009 - 2011
Professional Memberships
- Fellow
- Member
- American College of Medical GeneticsFellow
External Links
- MSKCC https://www.mskcc.org/cancer-care/doctors/michael-walsh
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: